These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 8565164)

  • 1. Acute cardiovascular effects of OPC-18790 in patients with congestive heart failure. Time- and dose-dependence analysis based on pressure-volume relations.
    Feldman MD; Pak PH; Wu CC; Haber HL; Heesch CM; Bergin JD; Powers ER; Cowart TD; Johnson W; Feldman AM; Kass DA
    Circulation; 1996 Feb; 93(3):474-83. PubMed ID: 8565164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct myocardial effects of OPC-18790 in human heart failure: beneficial effects on contractile and diastolic function demonstrated by intracoronary infusion with pressure-volume analysis.
    MacGowan GA; Haber HL; Cowart TD; Tedesco C; Wu C; Feldman MD
    J Am Coll Cardiol; 1998 May; 31(6):1344-51. PubMed ID: 9581731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of dobutamine and OPC-18790 on diastolic chamber stiffness in patients with idiopathic dilated cardiomyopathy.
    Machii T; Yokota M; Nagata K; Ishihara H; Iwase M; Sobue T
    J Cardiovasc Pharmacol; 1997 Feb; 29(2):265-72. PubMed ID: 9057077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute effects of a single low oral dose of pimobendan on left ventricular systolic and diastolic function in patients with congestive heart failure.
    Ishiki R; Ishihara T; Izawa H; Nagata K; Hirai M; Yokota M
    J Cardiovasc Pharmacol; 2000 Jun; 35(6):897-905. PubMed ID: 10836724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [End-systolic pressure-volume relationships obtained by conductance catheter and transient inferior vena caval occlusion: their clinical usefulness].
    Kameyama T; Asanoi H; Ishizaka S; Nozawa T; Fujita M; Sasayama S
    J Cardiol; 1991; 21(2):473-80. PubMed ID: 1668750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of a novel inotropic agent (OPC-18790) on systolic and diastolic function in patients with severe heart failure.
    Hoit BD; Burwig S; Eppert D; Bhat G; Walsh RA
    Am Heart J; 1994 Dec; 128(6 Pt 1):1156-63. PubMed ID: 7985596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel inotropic vasodilator, OPC-18790, reduces myocardial oxygen consumption and improves mechanical efficiency with congestive heart failure.
    Kanda H; Yokota M; Ishihara H; Nagata K; Kato R; Sobue T
    Am Heart J; 1996 Aug; 132(2 Pt 1):361-8. PubMed ID: 8701899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. OPC-18790, a novel positive inotropic agent, has both arterial and venous vascular dilating actions in the dog.
    Fujiki H; Mori T; Yoshida K; Imaizumi T; Tominaga M
    Eur J Pharmacol; 1996 Oct; 313(3):191-200. PubMed ID: 8911915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The differential effects of positive inotropic and vasodilator therapy on diastolic properties in patients with congestive cardiomyopathy.
    Carroll JD; Lang RM; Neumann AL; Borow KM; Rajfer SI
    Circulation; 1986 Oct; 74(4):815-25. PubMed ID: 3757193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative hemodynamic effects of OPC-18790 and dobutamine in patients with advanced heart failure.
    Abraham WT; Lowes BD; White M; Ferguson DA; Scheffel CA; Wolfel EE; Lindenfeld J; Bristow MR
    J Card Fail; 1994 Oct; 1(1):57-62. PubMed ID: 9420633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct myocardial effects of levosimendan in humans with left ventricular dysfunction: alteration of force-frequency and relaxation-frequency relationships.
    Givertz MM; Andreou C; Conrad CH; Colucci WS
    Circulation; 2007 Mar; 115(10):1218-24. PubMed ID: 17339544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral OPC-8212 for the treatment of congestive heart failure: hemodynamic improvement and increased exercise capacity.
    Inoue M; Kim BH; Hori M; Tsuneoka Y; Matsubara N; Kamada T; Kodama K; Naka M; Nanto S; Higashino Y
    Heart Vessels; 1986; 2(3):166-71. PubMed ID: 3793669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of OPC-18790, a new positive inotropic agent, on canine ventricular arrhythmias.
    Wu Z; Awaji T; Abe H; Motomura S; Hashimoto K
    Jpn J Pharmacol; 1993 Nov; 63(3):399-404. PubMed ID: 8107332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Separation of the direct myocardial and vasodilator actions of milrinone administered by an intracoronary infusion technique.
    Ludmer PL; Wright RF; Arnold JM; Ganz P; Braunwald E; Colucci WS
    Circulation; 1986 Jan; 73(1):130-7. PubMed ID: 3940664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positive inotropic and vasodilator actions of milrinone in patients with severe congestive heart failure. Dose-response relationships and comparison to nitroprusside.
    Jaski BE; Fifer MA; Wright RF; Braunwald E; Colucci WS
    J Clin Invest; 1985 Feb; 75(2):643-9. PubMed ID: 3973022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of action of OPC-8490 in human ventricular myocardium.
    Focaccio A; Peeters G; Movsesian M; Roden R; Eki Y; Krall J; Bristow MR
    Circulation; 1996 Feb; 93(4):817-25. PubMed ID: 8641012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sustained inotropic effects of a new cardiotonic agent. OPC-8212 in patients with chronic heart failure.
    Asanoi H; Sasayama S; Kameyama T; Ishizaka S; Iuchi K
    Clin Cardiol; 1989 Mar; 12(3):133-8. PubMed ID: 2647327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical efficacy of pimobendan (UD-CG 115 BS) in patients with chronic congestive heart failure.
    Baumann G; Ningel K; Permanetter B
    J Cardiovasc Pharmacol; 1989; 14 Suppl 2():S23-30. PubMed ID: 2478788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose dependence of chronic positive inotropic effect of vesnarinone in patients with congestive heart failure due to idiopathic or ischemic cardiomyopathy.
    Kass DA; Van Anden E; Becker LC; Kasper EK; White WB; Feldman AM
    Am J Cardiol; 1996 Sep; 78(6):652-6. PubMed ID: 8831399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular effects of the combination of OPC-18790 and dopamine in halothane-anesthetized dogs.
    Itoh S; Mori T; Yoshida K; Fujiki H; Tominaga M; Yabuuchi Y
    Jpn J Pharmacol; 1995 Nov; 69(3):229-37. PubMed ID: 8699631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.